Perbak Capital Partners’s Xylem XYL Stock Holding History

Perbak Capital Partners’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,664	Closed	-$557K	–	272
2026 Q1	$557K	Buy	+4,664	New	+$612K	0.14%	172

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Perbak Capital Partners's XYL Position: Q2 2026 in Review

Perbak Capital Partners sold out of Xylem (XYL) in Q2 2026, closing a stake of 4,664 shares — an estimated $557K sold.

Perbak Capital Partners first reported a position in XYL in Q1 2026 and held it in 1 quarter. The position peaked at $557K in Q1 2026. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Perbak Capital Partners reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 4,664 Xylem shares in Q2 2026, an estimated $557K.
Perbak Capital Partners first reported a position in Xylem in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Xylem position peaked at $557K in Q1 2026.
1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.